Skip to content

Clinical trials

Phase 2/3 Hypertension, Pulmonary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Phase: Phase 2/3 Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20091
20101
20113
20131
20163
20173
20182
20211
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Unknown status4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics2
University of Zurich2
Ain Shams University1
Aruna Nathan1
Asan Medical Center1
Carelon Research1
Center for Health Sciences, Serbia1
Franz Rischard, DO1
ICOS-Texas Biotechnology1
Insmed Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary22
Lung Diseases, Interstitial4
Emphysema2
Pulmonary Arterial Hypertension2
Cardiovascular Diseases1
Dyspnea1
Heart Failure, Diastolic1
Lung Diseases1
Pulmonary Fibrosis1
Sarcoidosis1

Trials

Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.